Melatonin and cadmium toxicity

Electronic Journal of Environmental, Agricultural and Food Chemistry

Volumn 7, Issue 8, 2008, Pages 3363-3371

  Lafuente, A ^a   Cabaleiro, T ^a   Caride, A ^a   Romero, A ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Cadmium; Free radicals; Melatonin; Oxidative stress

Indexed keywords

EID: 72149088179     PISSN: None     EISSN: 15794377     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. A. B. Lerner, J. D. Case, Y. Takahashi. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 80, 2587-2589 (1958).
2. C. S. Shida, A. M. Castrucci, M. T. Lamy-Freund. High melatonin solubility in aqueous medium. J. Pineal Res. 16, 198-201 (1994).
3. E. J. Costa, R. H. Lopes, M. T. Lamy-Freund. Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19,123-126 (1995).
4. Y. Okatani, K. Okamoto, K. Hayashi, A. Wakatsuki, S. Tamura, Y. Sagara. Maternal-fetal transfer of melatonin in pregnant women near term. J. Pineal Res. 25, 129-134 (1998).
5. A. Menendez-Pelaez, B. Poeggeler, R. J. Reiter, L. Barlow-Walden, M. I. Pablos, D. X. Tan Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell Biochem. 53, 373-382 (1993).
6. N. Zisapel. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs 15, 311-328 (2001).
7. R. J. Reiter. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12, 151-180 (1991).
8. F. A. Scheer, G. A. Van Montfrans, E. J. van Someren, G. Mairuhu, R. M. Buijs. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43, 192- 197 (2004).
9. A. Carrillo-Vico, J. M. Guerrero, P. J. Lardone, R. J. Reiter. A review of the multiple actions of melatonin on the immune system. Endocrine 27, 189-200 (2005).
10. D. E. Blask, G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer, M. A. Rivera-Bermudez, M. L. Dubocovich, S. A. Jasser, D. T. Lynch, M. D. Rollag, F. Zalatan. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65, 11174-11184 (2005).
11. S. Y. Shiu, N. Ng, S. F. Pang. A molecular perspective of the genetic relationships of G-protein coupled melatonin receptor subtypes. J. Pineal Res. 20, 198-204 (1996).
12. C. Carlberg. Gene regulation by melatonin. Ann. N. Y. Acad. Sci. 917, 387-396 (2000).
13. R. J. Reiter, D. X. Tan, L. C. Manchester, S. Lopez-Burillo, R. M. Sainz, J. C. Mayo. Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv. Exp. Med. Biol. 527, 539-548 (2003).
14. C. Rodriquez, J. C. Mayo, R. M. Sainz, I. Antolin, F. Herrera, V. Martin, R. J. Reiter. Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 36, 1-9 (2004).
15. K. Winiarska, T. Fraczyk, D. Malinska, J. Drozak, J. Bryla. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J. Pineal Res. 40, 168-176 (2006).
16. E. Gitto, D. X. Tan, R. J. Reiter, M. Karbownik, L. C. Manchester, S. Cuzzocrea, F. Fulia, I. Barberi. Individual and synergistic actions of melatonin: Studies with vitamin E, vitamin C, glutathione and desferoxamine in liver homogenates. J. Pharm. Pharmacol. 53, 1393-1401 (2001).
17. J. C. Mayo, D. X. Tan, R. M. Sainz, S. Lopez-Burillo, R. J. Reiter. Oxidative damage to catalase induced by peroxyl radicals: Functional protection by melatonin and other antioxidants. Free Radic. Res. 37, 543-553 (2003).
18. Y. Okatani, A. Wakatsuki, R. J. Reiter, H. Enzan, Y. Miyahara. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur. J. Pharmacol. 469, 145-152 (2003).
19. M. C. Henson, P. J. Chedrese. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp. Biol. Med. 229, 383-392 (2004).
20. E. K. Queiroz, W. Waissmann. Occupational exposure and effects on the male reproductive system. Cad. Saude Publica 22, 485-493 (2006).
21. A. Lafuente, A. I. Esquifino. Effects of oral cadmium exposure through puberty on plasma prolactin and gonadotropin levels and amino acid contents in various brain areas in pubertal male rats. Neurotoxicology 23, 207-213 (2002a).
22. M. Repetto, M. López-Artíguez. Estado actual de la toxicología del cadmio. In: Toxicología avanzada (M. Repeto, ed.), pp. 393-418. Díaz de Santos, Madrid (1995).
23. C. Rubio, A. Hardisson, J. I. Reguera, C. Reverst, A. Lafuente, T. González-Iglesias. Cadmium dietary intake in the Canary Islands, Spain. Environ. Res. 100, 123-129 (2006).
24. A. G. Sharret, A. P. Carter, R. M. Orhein, M. Feinleib. Daily intake of lead, cadmium, copper, and zinc from drinking water: the Seattle study of trace metal exposure. Environ. Res. 28, 456-475 (1982).
25. S. Satarug, M. R. Moore. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ. Health Perspect. 112, 1099-1103 (2004).
26. S. Satarug, P. Ujjin, Y. Vanavanitkun, J. R. Baker, M. R. Moore. Influence of body iron store status and cigarette smoking on cadmium body burden of healthy Thai women and men. Toxicol. Lett. 148, 177-185 (2004).
27. H. R. Pohl, H. Abadin, J. F. Risher. Neurotoxicity of Cadmium, Lead, and Mercury. In: Neurodegenerative diseases and metal ions (A. Sigel, H. Sigel, R. K. O. Sigel, eds.), pp. 474. Vol 1. John Wiley & Sons Ltd., West Sussex, England (2006).
28. V. A. Murphy. Cadmium: acute and chronic neurological disorders. In: Mineral and metal: neurotoxicology (M. Yasui, M. J. Strong, K. Ota, et al., eds.), pp. 229-240. Boca Raton: CRC. (1997).
29. A. Lafuente, A. González-Carracedo, A. Romero, A. I. Esquifino. Effect of cadmium on 24-h variations in hypothalamic dopamine and serotonin metabolism in adult male rats. Exp. Brain Res. 149, 200-206 (2003a).
30. W. Y. Ong, X. He, L. H. Chua, C. N. Ong. Increased uptake of divalent metals lead and cadmium into the brain after kainite-induced neuronal injury. Exp. Brain Res. 173, 468-474 (2006).
31. E. Y. Gutiérrez-Reyes, A. Albores, C. Ríos. Increase of striatal dopamine release by cadmium in nursing rats and its prevention by dexamethasone-induced metallothionein. Toxicology 131, 145-154 (1998).
32. A. Lafuente, A. I. Esquifino. Possible role of glutamate, aspartate, glutamine, GABA or taurine on cadmium toxicity on the hypothalamic pituitary axis activity in adult male rats. Biometals 15, 183-187 (2002b).
33. A. Lafuente, A. González-Carracedo, N. Márquez, D. Pazo, A. I. Esquifino. Oral cadmium exposure throughout puberty does not inhibit secretion of prolactin, GH and ACTH through dopamine metabolism changes in male rat. J. Trace Elem. Med. Biol. 16, 249-254 (2002a).
34. A. Lafuente, A. González-Carracedo, A. Romero, P. Cano, A. I. Esquifino. Cadmium exposure differentially modifies the circadian patterns of norepinephrine at the median eminence and plasma LH, FSH and testosterone levels. Toxicol. Lett. 146, 175-182 (2004).
35. A. Lafuente, A. González-Carracedo, A. Romero, T. Cabaleiro, A. I. Esquifino. Toxic effects of cadmium on the regulatory mechanism of dopamine and serotonin on prolactin secretion in adult male rats. Toxicol. Lett. 155, 87-96 (2005a).
36. A. Lafuente, A. Gonzalez-Carracedo, T. Cabaleiro, A. Romero, A. I. Esquifino. Toxic effects of cadmium on GABA and taurine content in different brain areas of adult male rats. J. Physiol. Biochem. 61, 439-446 (2005b).
37. A. Lafuente, N. Márquez, M. Pérez-Lorenzo, D. Pazo, A. I. Esquifino. Pubertal and postpubertal cadmium exposure differentially affects the hypothalamic-pituitary-testicular axis function in the rat. Food Chem. Toxicol. 38, 913-923 (2000b).
38. A. Lafuente, N. Márquez, D. Pazo, A. I. Esquifino. Cadmium effects on dopamine turnover and plasma levels of prolactin, GH and ACTH. J. Physiol. Biochem. 57, 231-236 (2001a).
39. A. Lafuente, N. Márquez, M. Pérez-Lorenzo, D. Pazo, A. I. Esquifino. Cadmium effects on hypothalamic-pituitary-testicular axis in male rats. Exp. Biol. Med. 226, 605-611 (2001b).
40. A. Lafuente, N. Marquez, D. Pazo, A. I. Esquifino. Effects of subchronic alternating cadmium exposure on dopamine turnover and plasma levels of prolactin, GH and ACTH. Biometals 13, 47-55 (2000c).
41. A. Romero. Envejecimiento y cronotoxicidad del cadmio en corteza prefrontal. Tesis de licenciatura. Universidad de Vigo (2004).
42. D. F. Swaab. The human hypothalamus: Basic and clinical aspects, Part I. In: Handbook of Clinical Neurology, Vol. 79 (3rd Series Vol. 1) (M. F. Aminoff, F. Boller, D. F. Swaab, eds.).Elsevier, Amsterdam (2003).
43. M. W. Decker, J. L. McGaugh. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7, 151-168 (1991).
44. A. Minetti, C. A. Reale. Sensorimotor developmental delays and lower anxiety in rats prenatally exposed to cadmium. J. Appl. Toxicol. 26, 35-41 (2006).
45. M. Waisberg, P. Joseph, B. Hale, D. Beyersmann. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192, 95-117 (2003).
46. M. Filipic, T. Fatur, M. Vudrag. Molecular mechanisms of cadmium induced mutagenicity. Hum. Exp. Toxicol. 25, 67-77 (2006).
47. P. H. Evans. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49, 577-587 (1995).
48. A. Hirano. Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol. 56, 91-101 (1991).
49. P. M. Sinet, I. Ceballos-Picot. Role of free radicals in Alzheimer's and Down's syndrome, Free Radicals in the Brain: Aging, Neurological and Mental Disorders. Pp. 91-98. Springer Verlag, Berlin (1992).
50. M. P. Waalkes. Metal carcinogenesis. In: Handbook of heavy metals in the environment (B. Sarkar, ed.) pp. 121-146. Marcel Dekker (2002).
51. T. Koizumi, H. Shirakura, H. Kumagai, H. Tatsumoto, K. T. Suzuki. Mechanism of cadmium-induced cytotoxicity in rat hepatocytes: cadmium-induced active oxygen-related permeability changes of the plasma membrane. Toxicology 114, 125-134 (1996).
52. F. Thevenod, J. M. Friedmann, A. D. Katsen, I. A. Hauser. Up-regulation of multidrug resistance Pglycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J. Biol. Chem. 275, 1887-1896 (2000).
53. G. Almazan, H. N. Liu, A. Khorchid, S. Sundarajan, A. K. Martinez-Bermudez, S. Chemtob. Exposure of developing oligodendrocytes to cadmium causes HSP72 induction, free radical generation, reduction in glutathione levels and cell death. Free Radic. Biol. Med. 29, 858-869 (2000).
54. G. Bertin, D. Averbeck. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie. 88, 1549-1559 (2006).
55. L. Xiao, D. R. Pimentel, J. Wang, K. Singh, W. S. Colucci, D. B. Sawyer. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol. Cell Physiol. 282, 926-934 (2002).
56. J. Gambhir, R. Nath. Effect of cadmium on tissue glutathione and glutathione peroxidase in rats: influence of selenium supplementation. Indian J. Exp. Biol. 30, 597-601 (1992).
57. Y. Wang, J. Fang, S. S. Leonard, K. M. Rao. Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic. Biol. Med. 36, 1434-1443 (2004).
58. T. Chakraborti, S. Das, M. Mondal, S. Roychoudhury, S. Chakraborti. Oxidant, mitochondria and calcium: an overview. Cell Signal 11, 77-85 (1999).
59. E. López, C. Arce, M. J. Oset-Gasque, S. Canadas, M. P. Gonzalez. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic. Biol. Med. 40, 940-951 (2006).
60. S. R. Pandi-Perumal, V. Srinivasan, G. J. Maestroni, D. P. Cardinali, B. Poeggeler, R. Hardeland. Melatonin: Nature's most versatile biological signal? FEBS J 273, 2813-2838 (2006).
61. R. J. Reiter, D. X. Tan, M. P. Terron, L. J. Flores, Z. Czarnocki. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim. Pol. 54, 1-9 (2007).
62. M. Karbownik, E. Gitto, A. Lewinski, R. J. Reiter. Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin. Cell Biol. Toxicol. 17, 33-40 (2001).
63. E. Chwelatiuk, T. Wlostowski, A. Krasowska, E. Bonda. The effect of orally administered melatonin on tissue accumulation and toxicity of cadmium in mice. J Trace Elem. Med. Biol. 19, 259-265 (2006).
64. A. H. Poliandri, A. I. Esquifino, P. Cano, V. Jimenez, A. Lafuente, D. P. Cardinali, B. H. Duvilanski. In vivo protective effect of melatonin on cadmium-induced changes in redox balance and gene expression in rat hypothalamus and anterior pituitary. J. Pineal Res. 41, 238-246 (2006).
65. C. Martinez-Campa, C. Alonso-Gonzalez, M. D. Mediavilla, S. Cos, A. Gonzalez, S. Ramos, E. J. Sanchez- Barcelo. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J. Pineal Res. 40, 291-296 (2006).
66. A. Romero. Estudio del posible papel protector de la melatonina frente a la toxicidad del cadmio sobre el sistema neuroendocrinológico. Doctoral Thesis. University of Vigo (2006).
67. J. Limson, T. Nyokong, S. Daya. The interaction of melatonin and its precursors with aluminium, cadmium, copper, iron, lead, and zinc: an adsorptive voltammetric study. J. Pineal Res. 24, 15-21 (1998).
68. R. J. Reiter, D. X. Tan, S. Burkhardt. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech. Ageing Dev. 123, 1007-1019 (2002).